These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

121 related items for PubMed ID: 7883840

  • 1. Pharmacokinetics, pharmacodynamics, and tolerability of cabergoline, a prolactin-lowering drug, after administration of increasing oral doses (0.5, 1.0, and 1.5 milligrams) in healthy male volunteers.
    Andreotti AC, Pianezzola E, Persiani S, Pacciarini MA, Strolin Benedetti M, Pontiroli AE.
    J Clin Endocrinol Metab; 1995 Mar; 80(3):841-5. PubMed ID: 7883840
    [Abstract] [Full Text] [Related]

  • 2. The effect of food on cabergoline pharmacokinetics and tolerability in healthy volunteers.
    Persiani S, Rocchetti M, Pacciarini MA, Holt B, Toon S, Strolin-Benedetti M.
    Biopharm Drug Dispos; 1996 Jul; 17(5):443-55. PubMed ID: 8830979
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Pharmacodynamics and relative bioavailability of cabergoline tablets vs solution in healthy volunteers.
    Persiani S, Sassolas G, Piscitelli G, Bizollon CA, Poggesi I, Pianezzola E, Edwards DM, Strolin Benedetti M.
    J Pharm Sci; 1994 Oct; 83(10):1421-4. PubMed ID: 7884663
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Cabergoline.
    Colao A, Lombardi G, Annunziato L.
    Expert Opin Pharmacother; 2000 Mar; 1(3):555-74. PubMed ID: 11249538
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Characterization of resistance to the prolactin-lowering effects of cabergoline in macroprolactinomas: a study in 122 patients.
    Delgrange E, Daems T, Verhelst J, Abs R, Maiter D.
    Eur J Endocrinol; 2009 May; 160(5):747-52. PubMed ID: 19223454
    [Abstract] [Full Text] [Related]

  • 11. Prolactinomas resistant to standard dopamine agonists respond to chronic cabergoline treatment.
    Colao A, Di Sarno A, Sarnacchiaro F, Ferone D, Di Renzo G, Merola B, Annunziato L, Lombardi G.
    J Clin Endocrinol Metab; 1997 Mar; 82(3):876-83. PubMed ID: 9062500
    [Abstract] [Full Text] [Related]

  • 12. Dose-related prolactin inhibitory effect of the new long-acting dopamine receptor agonist cabergoline in normal cycling, puerperal, and hyperprolactinemic women.
    Melis GB, Gambacciani M, Paoletti AM, Beneventi F, Mais V, Baroldi P, Fioretti P.
    J Clin Endocrinol Metab; 1987 Sep; 65(3):541-5. PubMed ID: 3624413
    [Abstract] [Full Text] [Related]

  • 13. Resistance to cabergoline as compared with bromocriptine in hyperprolactinemia: prevalence, clinical definition, and therapeutic strategy.
    Di Sarno A, Landi ML, Cappabianca P, Di Salle F, Rossi FW, Pivonello R, Di Somma C, Faggiano A, Lombardi G, Colao A.
    J Clin Endocrinol Metab; 2001 Nov; 86(11):5256-61. PubMed ID: 11701688
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Effect of cabergoline on metabolism in prolactinomas.
    Auriemma RS, Granieri L, Galdiero M, Simeoli C, Perone Y, Vitale P, Pivonello C, Negri M, Mannarino T, Giordano C, Gasperi M, Colao A, Pivonello R.
    Neuroendocrinology; 2013 Nov; 98(4):299-310. PubMed ID: 24355865
    [Abstract] [Full Text] [Related]

  • 19. Long-lasting lowering of serum growth hormone and prolactin levels by single and repetitive cabergoline administration in dopamine-responsive acromegalic patients.
    Ferrari C, Paracchi A, Romano C, Gerevini G, Boghen M, Barreca A, Fortini P, Dubini A.
    Clin Endocrinol (Oxf); 1988 Nov; 29(5):467-76. PubMed ID: 2908102
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.